Home / Industry / Pharmaceuticals & Biotechnology / Neoantigens Market

Neoantigens Market

Neoantigens Market Insights, Competitive Landscape, and Market Forecast - 2033

Published Date: May 2026 | Format: | No. of Pages: 185

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Sample / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Neoantigens Market

The Neoantigens market size is valued at USD 8.9 Bn in 2026.

The Neoantigens market is projected to grow at a CAGR of 35% by 2033.

The Neoantigens market growth drivers include rising cancer prevalence, increasing clinical trials in combination therapies, and advancements in cancer immunotherapy.

North America is a dominating region for Neoantigens market due to increasing clinical studies, breakthroughs in cancer therapies, and strong R&D investments.

BioNTech SE, Moderna, Inc., Gritstone bio, Inc., Merck & Co., Inc., and Immatics N.V. are some leading industry players in the Neoantigens market.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services